Quantcast

Latest Ergothioneine Stories

2010-09-07 07:30:00

BEVERLY HILLS, Calif., Sept. 7 /PRNewswire-FirstCall/ -- OXIS INTERNATIONAL, INC. (OTC Bulletin Board: OXIS, Paris: OXI) and THE ESTEE LAUDER COMPANIES INC. (NYSE: EL) announce today that they have resolved a dispute between an Estee Lauder subsidiary, Applied Genetics Incorporated Dermatics ("AGI"), and Oxis over technology related to U.S. Patent No. 6,103,746 (the "746 Patent") and U.S. Patent No. 6,479,533 (the "533 Patent"), entitled "Methods and Compositions for the Protection of...

2010-08-31 07:30:00

BEVERLY HILLS, Calif., Aug. 31 /PRNewswire-FirstCall/ -- OXIS INTERNATIONAL, INC. (OTC Bulletin Board: OXIS, Paris: OXI) announced today the launch of its wholly owned subsidiary, Oxis Consumer Products (OCP), focused on the development, marketing, promotion, and sales of direct to consumer brands. OCP will be responsible for sales, marketing and distribution of the recently announced ErgoFlex® and ErgoPLex® products as well as additional consumer...

2010-08-26 07:30:00

BEVERLY HILLS, Calif., Aug. 26 /PRNewswire-FirstCall/ -- OXIS INTERNATIONAL, INC. (OTC Bulletin Board: OXIS, Paris: OXI) is proud to announce that it has initiated active planning for the First World Congress on Ergothioneine, to be held in Los Angeles, California in July 2011 (the specific date will be announced at a later date). This first ever gathering of world experts in the fields of oxidative stress, healthy aging and chronic disease prevention and management will feature...

2010-08-24 07:30:00

BEVERLY HILLS, Calif., Aug. 24 /PRNewswire/ -- OXIS INTERNATIONAL, INC. (OTC Bulletin Board: OXIS, Paris: OXI) is proud to announce that it will introduce the benefits of Ergothioneine to the consumer market in September 2010 via breakthrough products for joint health and healthy aging. The first products, ErgoFlex® and ErgoPlex®, will initially be marketed via a direct mail offering being developed in partnership with Creative Direct Marketing Group,...

2010-08-19 07:30:00

BEVERLY HILLS, Calif., Aug. 19 /PRNewswire-FirstCall/ -- OXIS INTERNATIONAL, INC. (OTC Bulletin Board: OXIS, Paris: OXI) is proud to announce that an Oxis sponsored safety study of ergothioneine was published online on July 30, 2010 by the prestigious peer reviewed journal, TOXICOLOGY. The study, utilizing the well known "Ames Test" was conducted by researchers from the American Institute of Biomedical Research (Puyallup, WA) and Toxi-Coop Zrt. (Budapest, Hungary) and clearly demonstrated...

2010-08-18 08:25:00

BEVERLY HILLS, Calif., Aug. 18 /PRNewswire-FirstCall/ -- OXIS INTERNATIONAL, INC. (OTC Bulletin Board: OXIS, Paris: OXI), announced today that its senior management will be presenting at the Rodman & Renshaw Annual Global Investment Conference September 12th-15th. Chairman & CEO Tony Cataldo will introduce Oxis' new product line which leverages its patented super antioxidant Ergothioneine. Oxis continues to gain momentum in the multibillion dollar Nutraceuticals, Functional Food,...

2010-08-11 08:25:00

BEVERLY HILLS, Calif., Aug. 11 /PRNewswire-FirstCall/ -- OXIS INTERNATIONAL, INC. (OTC Bulletin Board: OXIS, Paris: OXI) announced today the addition of Dr. Stephen Coles as the newest member to its Scientific Advisory Board. The addition of Dr. Coles given his extensive research in the area of DNA, RNA and anti-aging will prove to be extremely beneficial in the company's product rollout. His vast body of clinical research highlighted vital information as to the importance of reducing free...

2010-06-30 08:25:00

BEVERLY HILLS, Calif., June 30 /PRNewswire-FirstCall/ -- OXIS INTERNATIONAL, INC. (OTC Bulletin Board: OXIS, Paris: OXI), is extremely pleased to announce that it has assumed control and future exploitation rights to International Patent PCT Application PCY/US2008/059831. The invention centers on the use of L-Ergothioneine ("ERGO") as a primary preservative for cells and tissue in culture. Such preservatives are essential for keeping cells in their "normal" state for later use or study and...

2010-06-23 08:25:00

BEVERLY HILLS, Calif., June 23 /PRNewswire-FirstCall/ -- OXIS INTERNATIONAL, INC. (OTC Bulletin Board: OXIS, Paris: OXI), announced today the appointment of Dr. Okezie Aruoma as President of its Scientific Advisory Board. Dr. Aruoma is considered to be the World's foremost leading researcher and authority on L-Ergothioneine (ERGO). Dr. Aruoma believes L-Ergothioneine to be the most profound and powerful antioxidant known to science with numerous use applications ranging from the treatment...

2010-06-16 08:25:00

BEVERLY HILLS, Calif., June 16 /PRNewswire-FirstCall/ -- OXIS International, Inc. (OTC Bulletin Board: OXIS, Paris: OXI), announced today the appointment of Sandep Rahi as CSO (Chief Strategist) and brand rollout advisor beginning immediately. Sandep is an EMMY award-winning Creative Director seasoned in both the entertainment and advertising industries. He has extensive experience establishing and overseeing strategic creative development and implementation for emerging and existing global...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related